XML 60 R45.htm IDEA: XBRL DOCUMENT v3.22.0.1
Earnings (Loss) Per Common Share (Tables)
12 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Computation of basic and diluted earnings per share
The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):
For the Year Ended December 31,
202120202019
Loss from continuing operations$(30,284)$(328,172)$(307,193)
Income (loss) from discontinued operations, net of tax(7,317)(6,074)1,613 
Net loss(37,601)(334,246)(305,580)
Less:
Net loss attributable to non-controlling interests— — (3,609)
Net loss available for common shareholders - basic and diluted$(37,601)$(334,246)$(301,971)
Weighted-average common shares outstanding - basic and diluted86,067 84,928 82,364 
Income (loss) per common share
Basic and diluted
Continuing operations$(0.35)$(3.86)$(3.73)
Discontinued operations(0.09)(0.08)0.02 
Non-controlling interests— — 0.04 
Basic and diluted income (loss) per share attributable to common shareholders of Evolent Health, Inc.$(0.44)$(3.94)$(3.67)
Schedule of antidilutive securities excluded from computation of earnings per share
Anti-dilutive shares (in thousands) excluded from the calculation of weighted-average common shares presented above are presented below:
For the Year Ended December 31,
202120202019
Exchangeable Class B common stock— — 1,399 
Restricted stock units ("RSUs"), performance-based RSUs and leveraged stock units ("LSUs")1,807 797 813 
Stock options2,036 1,141 1,324 
Convertible senior notes12,602 11,206 10,361 
Total16,445 13,144 13,897